Reply: Response to Nationwide Analysis of Antimicrobial Prescription in Korean Hospitals between 2018 and 2021: The 2023 KONAS Report
Infect Chemother
.
2024 Dec;56(4):557-558.
doi: 10.3947/ic.2024.0109.
Authors
I Ji Yun
#
1
,
Hyo Jung Park
#
2
3
,
Jungmi Chae
4
,
Yong Chan Kim
#
5
,
Bongyoung Kim
#
6
,
Jun Yong Choi
7
Affiliations
1
Department of pharmacy, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
2
Department of Pharmaceutical Services, Samsung Medical Center, Seoul, Korea.
3
School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
4
Health Insurance Review and Assessment (HIRA) Research Institute, Wonju, Korea.
5
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. AMOMJ@yuhs.ac.
6
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. sobakas@hanyang.ac.kr.
7
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
#
Contributed equally.
PMID:
39762932
DOI:
10.3947/ic.2024.0109
No abstract available
Publication types
Letter
Grants and funding
2022-ER2210-01/KDCA/Korea Disease Control and Prevention Agency/Korea